IGF2BP2 and breast carcinoma: With the increase of malignancy of breast cancer, the expression level of several m6A RNA methylation regulators, such as FTO, HNRNPA2B1 YTHDC1, IGF2BP1, IGF2BP2 and IGF2BP3, decreased or increased (Fig. 1C).